Prof. Dr. Hans-Jürgen Möller
Prof. Dr. Hans-Jürgen Möller
Universitätsprofessor für Psychiatrie, Psychiatrische Klinik der Maximilians-Universität München
Verified email at - Homepage
Cited by
Cited by
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (Arabic verson)
M De Hert, C Correll, J Bobes, M Cetkovick-Bakmans, DAN Cohen, I Asia, ...
World psychiatry 10 (1), 52-77, 2011
Large recurrent microdeletions associated with schizophrenia
H Stefansson, D Rujescu, S Cichon, OPH Pietiläinen, A Ingason, ...
nature 455 (7210), 232-236, 2008
Common variants conferring risk of schizophrenia
H Stefansson, RA Ophoff, S Steinberg, OA Andreassen, S Cichon, ...
Nature 460 (7256), 744-747, 2009
Identification of loci associated with schizophrenia by genome-wide association and follow-up
MC O'donovan, N Craddock, N Norton, H Williams, T Peirce, V Moskvina, ...
Nature genetics 40 (9), 1053-1055, 2008
Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders
HS Akiskal, ML Bourgeois, J Angst, R Post, HJ Möller, R Hirschfeld
Journal of affective disorders 59, S5-S30, 2000
Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European …
M De Hert, JM Dekker, D Wood, KG Kahl, RIG Holt, HJ Möller
European psychiatry 24 (6), 412-424, 2009
Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level
M De Hert, DAN Cohen, J Bobes, M Cetkovich-Bakmas, S Leucht, ...
World psychiatry 10 (2), 138, 2011
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
N Müller, MJ Schwarz, S Dehning, A Douhe, A Cerovecki, ...
Molecular psychiatry 11 (7), 680-684, 2006
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders …
B Bandelow, J Zohar, E Hollander, S Kasper, HJ Möller, ...
The World Journal of Biological Psychiatry 9 (4), 248-312, 2008
The Effects of Donepezil in Alzheimer’s Disease–Results from a Multinational Trial1
A Burns, M Rossor, J Hecker, S Gauthier, H Petit, HJ Möller, SL Rogers, ...
Dementia and geriatric cognitive disorders 10 (3), 237-244, 1999
Hippocampal changes in patients with a first episode of major depression
T Frodl, EM Meisenzahl, T Zetzsche, C Born, C Groll, M Jäger, ...
American Journal of Psychiatry 159 (7), 1112-1118, 2002
Integration of fMRI and simultaneous EEG: towards a comprehensive understanding of localization and time-course of brain activity in target detection
C Mulert, L Jäger, R Schmitt, P Bussfeld, O Pogarell, HJ Möller, G Juckel, ...
Neuroimage 22 (1), 83-94, 2004
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology
OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ...
American Journal of Psychiatry 174 (3), 216-229, 2017
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders, part I: treatment of bipolar depression
H Grunze, S Kasper, G Goodwin, C Bowden, D Baldwin, R Licht, E Vieta, ...
The World Journal of Biological Psychiatry 3 (3), 115-124, 2002
Social functioning in depression: a review
RM Hirschfeld, SA Montgomery, MB Keller, S Kasper, AF Schatzberg, ...
Journal of Clinical Psychiatry 61 (4), 268-275, 2000
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of …
A Hasan, P Falkai, T Wobrock, J Lieberman, B Glenthoj, WF Gattaz, ...
The world journal of biological psychiatry 14 (1), 2-44, 2013
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia …
A Hasan, P Falkai, T Wobrock, J Lieberman, B Glenthoj, WF Gattaz, ...
The World Journal of Biological Psychiatry 13 (5), 318-378, 2012
Prefrontal transcranial direct current stimulation changes connectivity of resting-state networks during fMRI
D Keeser, T Meindl, J Bor, U Palm, O Pogarell, C Mulert, J Brunelin, ...
Journal of Neuroscience 31 (43), 15284-15293, 2011
Disruption of the neurexin 1 gene is associated with schizophrenia
D Rujescu, A Ingason, S Cichon, OPH Pietiläinen, MR Barnes, ...
Human molecular genetics 18 (5), 988-996, 2009
Measurement of phosphorylated tau epitopes in the differential diagnosisof Alzheimer disease: a comparative cerebrospinal fluid study
H Hampel, K Buerger, R Zinkowski, SJ Teipel, A Goernitz, N Andreasen, ...
Archives of general psychiatry 61 (1), 95-102, 2004
The system can't perform the operation now. Try again later.
Articles 1–20